CITIUS ONCOLOGY INC (CTOR) Stock Cash Flow
NASDAQ:CTOR - Nasdaq - US17331Y1091 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-9-30) | 2023 (2023-9-30) | ||||
|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||
| Net Income | N/A | 2.42M | 380.80K | |||
| Income Taxes - Deferred | N/A | 576.00K | 576.00K | |||
| Change In Working Capital | N/A | 411.80K | 64.20K | |||
| Other non cash items | N/A | -3.43M | -493.00K | |||
| OPERATING CASH FLOW | N/A | -601.30K | -48.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||
| Other Investing Activity | N/A | -1.32M | -67.32M | |||
| INVESTING CASH FLOW | N/A | -1.32M | -67.32M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||
| Debt Issued/Reduced | N/A | 1.32M | -130.70K | |||
| Stock Issued/Repurchased | N/A | N/A | 66.03M | |||
| Other Financing Activity | N/A | 344.90K | 1.76M | |||
| FINANCING CASH FLOW | N/A | 1.66M | 67.66M | |||
| CHANGE IN CASH | N/A | -256.40K | 289.20K | |||
| FREE CASH FLOW | ||||||
| Operating Cash Flow | N/A | -601.30K | -48.00K | |||
| FREE CASH FLOW | N/A | -601.30K | -48.00K | |||
All data in USD